by Kevin M. Cahill, M.D., D.T.M. & H. (Lond.), Head, Department of Epidemiology, Director of Tropical Medicine, U.S. Naval Medical Research Unit No. 3, Egypt and The Sudan. xiii + 225 pages, illustrated. J. B. Lippincott Company, Philadelphia and Montreal. 1964. $9.50
Investigations of the duration of the prepatent period and of the early clinical course of falciparum malaria (McLendon strain) were conducted with 16 non-immune American Negro men. Eight of the men were glucose-6-phosphate dehydrogenase (G6PD)-deficient and 8 were not. The investigations did not disclose evidence supporting the hypothesis that G6PD deficiency confers a biologic advantage against falciparum malaria.